| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 2.38e-08 | 130 | 103 | 9 | GO:0005200 | |
| GeneOntologyMolecularFunction | double-stranded RNA binding | 3.09e-06 | 78 | 103 | 6 | GO:0003725 | |
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 2.64e-05 | 2 | 103 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 2.64e-05 | 2 | 103 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 7.88e-05 | 3 | 103 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | actin filament binding | 1.76e-04 | 227 | 103 | 7 | GO:0051015 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 3.56e-04 | 27 | 103 | 3 | GO:0008066 | |
| GeneOntologyMolecularFunction | calcium channel activity | 5.49e-04 | 129 | 103 | 5 | GO:0005262 | |
| GeneOntologyMolecularFunction | glutamate-gated calcium ion channel activity | 7.23e-04 | 8 | 103 | 2 | GO:0022849 | |
| GeneOntologyMolecularFunction | NMDA glutamate receptor activity | 7.23e-04 | 8 | 103 | 2 | GO:0004972 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 7.74e-04 | 35 | 103 | 3 | GO:0015020 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.12e-03 | 151 | 103 | 5 | GO:0015085 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | NES MYH10 MYO9A STXBP5 SYNE1 GRIN1 ITGB3 DIP2A MAP1S TUBA1A PRKCZ SEMA4A EP300 PACSIN2 VCL | 1.66e-05 | 826 | 104 | 15 | GO:0048858 |
| GeneOntologyBiologicalProcess | mitotic cell cycle | NES MYH10 TUBA3D YTHDC2 TUBA8 CREBBP TUBA4A TUBA3C TUBA1B MAP1S TUBA1A ABRAXAS1 PKD1 SASS6 LRP5 USP47 | 4.67e-05 | 1014 | 104 | 16 | GO:0000278 |
| GeneOntologyBiologicalProcess | startle response | 5.35e-05 | 41 | 104 | 4 | GO:0001964 | |
| GeneOntologyCellularComponent | postsynapse | MYH10 ANK2 SWAP70 SPOCK1 MYO9A SYNE1 SPTB SPTBN2 GRIN1 GRIN2C GRM7 ITGB3 DIP2A PRKCZ CADPS2 UTRN | 4.71e-05 | 1018 | 105 | 16 | GO:0098794 |
| GeneOntologyCellularComponent | parallel fiber to Purkinje cell synapse | 6.38e-05 | 43 | 105 | 4 | GO:0098688 | |
| GeneOntologyCellularComponent | synaptic membrane | ANK2 CACNA2D2 STXBP5 SYNE1 GRIN1 GRIN2C GRM7 ITGB3 OTOF CADPS2 UTRN | 1.68e-04 | 583 | 105 | 11 | GO:0097060 |
| GeneOntologyCellularComponent | neuromuscular junction | 2.55e-04 | 112 | 105 | 5 | GO:0031594 | |
| GeneOntologyCellularComponent | deuterosome | 3.70e-04 | 6 | 105 | 2 | GO:0098536 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 6.44e-04 | 78 | 105 | 4 | GO:0048787 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 6.86e-04 | 8 | 105 | 2 | GO:1990723 | |
| GeneOntologyCellularComponent | glutamatergic synapse | MYH10 MYO9A SPTB SPTBN2 GRIN1 GRIN2C GRM7 ITGB3 DIP2A PRKCZ CADPS2 PACSIN2 | 8.17e-04 | 817 | 105 | 12 | GO:0098978 |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 8.79e-04 | 9 | 105 | 2 | GO:0014731 | |
| GeneOntologyCellularComponent | NMDA selective glutamate receptor complex | 8.79e-04 | 9 | 105 | 2 | GO:0017146 | |
| GeneOntologyCellularComponent | spectrin | 8.79e-04 | 9 | 105 | 2 | GO:0008091 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 1.01e-03 | 405 | 105 | 8 | GO:0045211 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 1.10e-03 | 10 | 105 | 2 | GO:0044614 | |
| GeneOntologyCellularComponent | paranodal junction | 1.33e-03 | 11 | 105 | 2 | GO:0033010 | |
| HumanPheno | Epileptic encephalopathy | 2.28e-07 | 119 | 40 | 9 | HP:0200134 | |
| HumanPheno | Plantar crease between first and second toes | 6.01e-05 | 2 | 40 | 2 | HP:0008107 | |
| HumanPheno | Aortic isthmus hypoplasia | 6.01e-05 | 2 | 40 | 2 | HP:0034227 | |
| HumanPheno | High axial triradius | 6.01e-05 | 2 | 40 | 2 | HP:0001042 | |
| HumanPheno | Syringomyelia | 1.13e-04 | 33 | 40 | 4 | HP:0003396 | |
| HumanPheno | Aspiration | 1.28e-04 | 34 | 40 | 4 | HP:0002835 | |
| HumanPheno | Epileptic spasm | 1.62e-04 | 207 | 40 | 8 | HP:0011097 | |
| HumanPheno | Self-injurious behavior | 1.79e-04 | 210 | 40 | 8 | HP:0100716 | |
| HumanPheno | Laryngeal cartilage malformation | 1.79e-04 | 3 | 40 | 2 | HP:0008752 | |
| HumanPheno | Phobia | 1.79e-04 | 3 | 40 | 2 | HP:5200232 | |
| HumanPheno | Agoraphobia | 1.79e-04 | 3 | 40 | 2 | HP:0000756 | |
| HumanPheno | Humoral immunodeficiency | 1.79e-04 | 3 | 40 | 2 | HP:0005363 | |
| HumanPheno | Prominent nasal septum | 1.79e-04 | 3 | 40 | 2 | HP:0005322 | |
| HumanPheno | Radial deviation of thumb terminal phalanx | 1.79e-04 | 3 | 40 | 2 | HP:0005895 | |
| HumanPheno | Encephalopathy | DPAGT1 RANBP2 POLR1A CACNA2D2 CHD2 GRIN1 CHKA KCNT2 CARS2 MAST3 | 1.89e-04 | 335 | 40 | 10 | HP:0001298 |
| HumanPheno | Tube feeding | 2.11e-04 | 215 | 40 | 8 | HP:0033454 | |
| HumanPheno | Brain imaging abnormality | 2.68e-04 | 167 | 40 | 7 | HP:0410263 | |
| HumanPheno | Hypoplastic hippocampus | 2.83e-04 | 17 | 40 | 3 | HP:0025517 | |
| HumanPheno | Generalized-onset motor seizure | 3.16e-04 | 228 | 40 | 8 | HP:0032677 | |
| HumanPheno | Obstructive sleep apnea | 3.40e-04 | 79 | 40 | 5 | HP:0002870 | |
| HumanPheno | Trichiasis | 3.57e-04 | 4 | 40 | 2 | HP:0001128 | |
| HumanPheno | Visceral hemangioma | 3.57e-04 | 4 | 40 | 2 | HP:0410266 | |
| HumanPheno | Talon cusp | 3.57e-04 | 4 | 40 | 2 | HP:0011087 | |
| HumanPheno | Widened distal phalanges | 3.57e-04 | 4 | 40 | 2 | HP:0006200 | |
| HumanPheno | Vascular ring | 3.57e-04 | 4 | 40 | 2 | HP:0010775 | |
| HumanPheno | Hepatic hemangioma | 3.57e-04 | 4 | 40 | 2 | HP:0031207 | |
| HumanPheno | Absent speech | DPAGT1 MAGEL2 POLR1A CACNA2D2 GRIN1 TUBA8 CHKA CREBBP PRKCZ CARS2 EP300 | 3.74e-04 | 436 | 40 | 11 | HP:0001344 |
| HumanPheno | Spinal cord lesion | 4.20e-04 | 46 | 40 | 4 | HP:0100561 | |
| HumanPheno | Broad phalanx of the toes | 4.56e-04 | 47 | 40 | 4 | HP:0010174 | |
| HumanPheno | Abnormal hippocampus morphology | 4.95e-04 | 48 | 40 | 4 | HP:0025100 | |
| HumanPheno | Abnormal morphology of the limbic system | 5.36e-04 | 49 | 40 | 4 | HP:0007343 | |
| HumanPheno | Papillary cystadenoma of the epididymis | 5.92e-04 | 5 | 40 | 2 | HP:0009715 | |
| HumanPheno | Supernumerary cusp | 5.92e-04 | 5 | 40 | 2 | HP:0033777 | |
| HumanPheno | Epididymal neoplasm | 5.92e-04 | 5 | 40 | 2 | HP:0030421 | |
| HumanPheno | Deficiency of speech development | DPAGT1 MAGEL2 POLR1A CACNA2D2 GRIN1 TUBA8 CHKA CREBBP PRKCZ CARS2 EP300 | 6.27e-04 | 463 | 40 | 11 | HP:0002116 |
| HumanPheno | Tonic seizure | 6.88e-04 | 140 | 40 | 6 | HP:0032792 | |
| HumanPheno | Atonic seizure | 7.59e-04 | 94 | 40 | 5 | HP:0010819 | |
| Domain | DZF | 4.86e-12 | 5 | 104 | 5 | SM00572 | |
| Domain | DZF_dom | 4.86e-12 | 5 | 104 | 5 | IPR006561 | |
| Domain | DZF | 4.86e-12 | 5 | 104 | 5 | PF07528 | |
| Domain | DZF | 4.86e-12 | 5 | 104 | 5 | PS51703 | |
| Domain | Alpha_tubulin | 6.01e-10 | 9 | 104 | 5 | IPR002452 | |
| Domain | Tubulin_C | 1.19e-07 | 22 | 104 | 5 | PF03953 | |
| Domain | Tubulin/FtsZ_2-layer-sand-dom | 1.19e-07 | 22 | 104 | 5 | IPR018316 | |
| Domain | Tubulin_C | 1.19e-07 | 22 | 104 | 5 | SM00865 | |
| Domain | Tub_FtsZ_C | 1.51e-07 | 23 | 104 | 5 | IPR008280 | |
| Domain | Tubulin_C | 1.51e-07 | 23 | 104 | 5 | IPR023123 | |
| Domain | TUBULIN | 1.51e-07 | 23 | 104 | 5 | PS00227 | |
| Domain | Tubulin | 1.51e-07 | 23 | 104 | 5 | IPR000217 | |
| Domain | Tubulin | 1.51e-07 | 23 | 104 | 5 | SM00864 | |
| Domain | Tubulin_CS | 1.51e-07 | 23 | 104 | 5 | IPR017975 | |
| Domain | Tubulin_FtsZ_GTPase | 1.90e-07 | 24 | 104 | 5 | IPR003008 | |
| Domain | Tubulin | 1.90e-07 | 24 | 104 | 5 | PF00091 | |
| Domain | - | 4.10e-06 | 20 | 104 | 4 | 3.30.1330.20 | |
| Domain | - | 5.05e-06 | 21 | 104 | 4 | 1.10.287.600 | |
| Domain | - | 6.14e-06 | 22 | 104 | 4 | 3.40.50.1440 | |
| Domain | Spectrin | 7.40e-06 | 23 | 104 | 4 | PF00435 | |
| Domain | ACTININ_2 | 7.40e-06 | 23 | 104 | 4 | PS00020 | |
| Domain | ACTININ_1 | 7.40e-06 | 23 | 104 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 7.40e-06 | 23 | 104 | 4 | IPR001589 | |
| Domain | Spectrin_repeat | 1.94e-05 | 29 | 104 | 4 | IPR002017 | |
| Domain | SPEC | 2.89e-05 | 32 | 104 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.89e-05 | 32 | 104 | 4 | IPR018159 | |
| Domain | Nuc_rcpt_coact_CREBbp | 3.07e-05 | 2 | 104 | 2 | IPR014744 | |
| Domain | ZnF_TAZ | 3.07e-05 | 2 | 104 | 2 | SM00551 | |
| Domain | - | 3.07e-05 | 2 | 104 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 3.07e-05 | 2 | 104 | 2 | IPR010303 | |
| Domain | - | 3.07e-05 | 2 | 104 | 2 | 1.10.1630.10 | |
| Domain | Creb_binding | 3.07e-05 | 2 | 104 | 2 | PF09030 | |
| Domain | zf-TAZ | 3.07e-05 | 2 | 104 | 2 | PF02135 | |
| Domain | ZF_TAZ | 3.07e-05 | 2 | 104 | 2 | PS50134 | |
| Domain | KAT11 | 3.07e-05 | 2 | 104 | 2 | SM01250 | |
| Domain | Znf_TAZ | 3.07e-05 | 2 | 104 | 2 | IPR000197 | |
| Domain | KIX | 3.07e-05 | 2 | 104 | 2 | PF02172 | |
| Domain | HAT_KAT11 | 3.07e-05 | 2 | 104 | 2 | PF08214 | |
| Domain | KIX | 3.07e-05 | 2 | 104 | 2 | PS50952 | |
| Domain | CBP_P300_HAT | 3.07e-05 | 2 | 104 | 2 | IPR031162 | |
| Domain | DUF902 | 3.07e-05 | 2 | 104 | 2 | PF06001 | |
| Domain | - | 3.07e-05 | 2 | 104 | 2 | 1.10.246.20 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 3.07e-05 | 2 | 104 | 2 | IPR013178 | |
| Domain | KIX_dom | 3.07e-05 | 2 | 104 | 2 | IPR003101 | |
| Domain | CBP_P300_HAT | 3.07e-05 | 2 | 104 | 2 | PS51727 | |
| Domain | Ran_BP1 | 3.56e-05 | 12 | 104 | 3 | PF00638 | |
| Domain | RANBD1 | 3.56e-05 | 12 | 104 | 3 | PS50196 | |
| Domain | RanBD | 4.61e-05 | 13 | 104 | 3 | SM00160 | |
| Domain | Ran_bind_dom | 4.61e-05 | 13 | 104 | 3 | IPR000156 | |
| Domain | ZF_ZZ_2 | 1.29e-04 | 18 | 104 | 3 | PS50135 | |
| Domain | ZF_ZZ_1 | 1.29e-04 | 18 | 104 | 3 | PS01357 | |
| Domain | ZZ | 1.29e-04 | 18 | 104 | 3 | PF00569 | |
| Domain | Znf_ZZ | 1.52e-04 | 19 | 104 | 3 | IPR000433 | |
| Domain | ZnF_ZZ | 1.52e-04 | 19 | 104 | 3 | SM00291 | |
| Domain | Spectrin_bsu | 1.83e-04 | 4 | 104 | 2 | IPR016343 | |
| Domain | UDPGT | 2.07e-04 | 21 | 104 | 3 | PF00201 | |
| Domain | UDPGT | 2.07e-04 | 21 | 104 | 3 | PS00375 | |
| Domain | UDP_glucos_trans | 2.07e-04 | 21 | 104 | 3 | IPR002213 | |
| Domain | Nuc_rcpt_coact | 4.54e-04 | 6 | 104 | 2 | IPR009110 | |
| Domain | CH | 4.73e-04 | 65 | 104 | 4 | SM00033 | |
| Domain | CH | 6.27e-04 | 70 | 104 | 4 | PF00307 | |
| Domain | - | 6.62e-04 | 71 | 104 | 4 | 1.10.418.10 | |
| Domain | CH | 7.35e-04 | 73 | 104 | 4 | PS50021 | |
| Domain | CH-domain | 8.14e-04 | 75 | 104 | 4 | IPR001715 | |
| Domain | SPARC/Testican_Ca-bd-dom | 8.41e-04 | 8 | 104 | 2 | IPR019577 | |
| Domain | SPARC_Ca_bdg | 8.41e-04 | 8 | 104 | 2 | PF10591 | |
| Domain | ANF_lig-bd_rcpt | 1.14e-03 | 37 | 104 | 3 | IPR001828 | |
| Domain | ANF_receptor | 1.14e-03 | 37 | 104 | 3 | PF01094 | |
| Domain | Peripla_BP_I | 1.33e-03 | 39 | 104 | 3 | IPR028082 | |
| Domain | Grip | 1.63e-03 | 11 | 104 | 2 | SM00755 | |
| Domain | GRIP | 1.63e-03 | 11 | 104 | 2 | PF01465 | |
| Domain | GRIP_dom | 1.95e-03 | 12 | 104 | 2 | IPR000237 | |
| Domain | GRIP | 1.95e-03 | 12 | 104 | 2 | PS50913 | |
| Domain | - | 2.65e-03 | 248 | 104 | 6 | 1.25.40.20 | |
| Domain | ANK | 2.81e-03 | 251 | 104 | 6 | SM00248 | |
| Domain | ANK_REPEAT | 2.92e-03 | 253 | 104 | 6 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 2.98e-03 | 254 | 104 | 6 | IPR020683 | |
| Domain | ANK_REP_REGION | 2.98e-03 | 254 | 104 | 6 | PS50297 | |
| Domain | Ankyrin_rpt | 3.47e-03 | 262 | 104 | 6 | IPR002110 | |
| Domain | - | 3.95e-03 | 17 | 104 | 2 | 4.10.800.10 | |
| Domain | Thyroglobulin_1 | 3.95e-03 | 17 | 104 | 2 | IPR000716 | |
| Domain | THYROGLOBULIN_1_1 | 3.95e-03 | 17 | 104 | 2 | PS00484 | |
| Domain | TY | 3.95e-03 | 17 | 104 | 2 | SM00211 | |
| Domain | THYROGLOBULIN_1_2 | 3.95e-03 | 17 | 104 | 2 | PS51162 | |
| Domain | Thyroglobulin_1 | 3.95e-03 | 17 | 104 | 2 | PF00086 | |
| Domain | LH2 | 4.43e-03 | 18 | 104 | 2 | SM00308 | |
| Domain | Lig_chan-Glu_bd | 4.43e-03 | 18 | 104 | 2 | PF10613 | |
| Domain | Glu/Gly-bd | 4.43e-03 | 18 | 104 | 2 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 4.43e-03 | 18 | 104 | 2 | SM00918 | |
| Domain | Iontro_rcpt | 4.43e-03 | 18 | 104 | 2 | IPR001320 | |
| Domain | Iono_rcpt_met | 4.43e-03 | 18 | 104 | 2 | IPR001508 | |
| Domain | Lig_chan | 4.43e-03 | 18 | 104 | 2 | PF00060 | |
| Domain | PBPe | 4.43e-03 | 18 | 104 | 2 | SM00079 | |
| Domain | DSRM | 4.94e-03 | 19 | 104 | 2 | SM00358 | |
| Domain | dsrm | 5.47e-03 | 20 | 104 | 2 | PF00035 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 1.13e-10 | 44 | 80 | 8 | M27934 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 3.25e-10 | 17 | 80 | 6 | M47768 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT | 4.85e-10 | 18 | 80 | 6 | M47753 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT | 7.06e-10 | 19 | 80 | 6 | M47818 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT | 7.06e-10 | 19 | 80 | 6 | M47813 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT | 1.00e-09 | 20 | 80 | 6 | M47890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS | 1.00e-09 | 20 | 80 | 6 | M47911 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 1.40e-09 | 21 | 80 | 6 | M27067 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 1.40e-09 | 21 | 80 | 6 | M47767 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | ANK2 TUBA3D SPTB SPTBN2 TUBA8 ITGB3 TUBA4A TUBA3C TUBA1B TUBA1A | 1.48e-09 | 121 | 80 | 10 | M872 |
| Pathway | KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH | 1.92e-09 | 22 | 80 | 6 | M47903 | |
| Pathway | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | 2.58e-09 | 23 | 80 | 6 | M19135 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION | 2.58e-09 | 23 | 80 | 6 | M47910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION | 2.58e-09 | 23 | 80 | 6 | M47900 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT | 3.42e-09 | 24 | 80 | 6 | M47671 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 3.42e-09 | 24 | 80 | 6 | M47700 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 4.22e-09 | 68 | 80 | 8 | MM14968 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 4.49e-09 | 25 | 80 | 6 | M47775 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 4.49e-09 | 25 | 80 | 6 | M47710 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 5.76e-09 | 102 | 80 | 9 | M27648 | |
| Pathway | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | 5.81e-09 | 26 | 80 | 6 | M9648 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT | 5.81e-09 | 26 | 80 | 6 | M47672 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION | 9.42e-09 | 28 | 80 | 6 | M47898 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 1.04e-08 | 76 | 80 | 8 | M48037 | |
| Pathway | REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS | 1.18e-08 | 29 | 80 | 6 | M27948 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | MYH10 ANK2 TUBA3D SPTB SPTBN2 SREBF2 COL6A5 GRIN1 TUBA8 ITGB3 TUBA4A TUBA3C TUBA1B TUBA1A PIK3CB SEMA4A UTRN | 1.76e-08 | 575 | 80 | 17 | M29853 |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 2.22e-08 | 32 | 80 | 6 | M29848 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 2.22e-08 | 32 | 80 | 6 | M27491 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | TUBA3D SPTB SPTBN2 COL6A5 GRIN1 TUBA8 ITGB3 TUBA4A TUBA1B TUBA1A PIK3CB SEMA4A | 2.49e-08 | 261 | 80 | 12 | MM15676 |
| Pathway | REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING | 2.71e-08 | 33 | 80 | 6 | M27297 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION | 2.71e-08 | 33 | 80 | 6 | M47901 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 3.04e-08 | 17 | 80 | 5 | MM14731 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 3.93e-08 | 35 | 80 | 6 | M47774 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 5.65e-08 | 94 | 80 | 8 | M2843 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 6.60e-08 | 38 | 80 | 6 | M14981 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 8.63e-08 | 66 | 80 | 7 | MM17074 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 1.42e-07 | 43 | 80 | 6 | M47669 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT | 1.42e-07 | 43 | 80 | 6 | M47773 | |
| Pathway | REACTOME_AGGREPHAGY | 1.64e-07 | 44 | 80 | 6 | M29830 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 1.77e-07 | 151 | 80 | 9 | M550 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 1.89e-07 | 45 | 80 | 6 | M47670 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 2.16e-07 | 46 | 80 | 6 | M27828 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 2.34e-07 | 156 | 80 | 9 | M27097 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 3.18e-07 | 49 | 80 | 6 | M891 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 3.80e-07 | 27 | 80 | 5 | MM15549 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 3.80e-07 | 27 | 80 | 5 | MM15674 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 4.06e-07 | 51 | 80 | 6 | M26972 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 5.13e-07 | 53 | 80 | 6 | M27651 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 5.54e-07 | 29 | 80 | 5 | MM15219 | |
| Pathway | WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 6.41e-07 | 55 | 80 | 6 | M39613 | |
| Pathway | KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 7.15e-07 | 56 | 80 | 6 | M2333 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 7.96e-07 | 57 | 80 | 6 | M27251 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 9.26e-07 | 32 | 80 | 5 | MM14730 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 9.99e-07 | 94 | 80 | 7 | MM14515 | |
| Pathway | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | 1.08e-06 | 187 | 80 | 9 | M961 | |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | 1.10e-06 | 138 | 80 | 8 | M29805 | |
| Pathway | REACTOME_KINESINS | 1.20e-06 | 61 | 80 | 6 | M977 | |
| Pathway | REACTOME_AGGREPHAGY | 1.70e-06 | 36 | 80 | 5 | MM15669 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 1.96e-06 | 37 | 80 | 5 | MM15102 | |
| Pathway | WP_ALZHEIMERS_DISEASE | TUBA3D GRIN1 GRIN2C TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A PIK3CB LRP5 | 2.10e-06 | 261 | 80 | 10 | M42565 |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 2.89e-06 | 110 | 80 | 7 | MM15350 | |
| Pathway | WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY | 2.95e-06 | 71 | 80 | 6 | M39690 | |
| Pathway | REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE | 3.20e-06 | 72 | 80 | 6 | M26954 | |
| Pathway | REACTOME_HCMV_INFECTION | 3.68e-06 | 162 | 80 | 8 | M29804 | |
| Pathway | BIOCARTA_MTA3_PATHWAY | 4.35e-06 | 20 | 80 | 4 | MM1383 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 4.40e-06 | 76 | 80 | 6 | M27215 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 4.74e-06 | 44 | 80 | 5 | MM14606 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 5.52e-06 | 79 | 80 | 6 | M27743 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 7.13e-06 | 126 | 80 | 7 | M705 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 7.34e-06 | 48 | 80 | 5 | MM15353 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 7.51e-06 | 127 | 80 | 7 | M27181 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 8.33e-06 | 129 | 80 | 7 | MM14894 | |
| Pathway | REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION | DPAGT1 ANK2 TUBA3D SPTB SPTBN2 TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A | 8.86e-06 | 307 | 80 | 10 | M894 |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 1.09e-05 | 52 | 80 | 5 | MM14949 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 1.18e-05 | 90 | 80 | 6 | M29841 | |
| Pathway | KEGG_GAP_JUNCTION | 1.18e-05 | 90 | 80 | 6 | M4013 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 1.30e-05 | 138 | 80 | 7 | MM15635 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 1.32e-05 | 54 | 80 | 5 | M27482 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 1.42e-05 | 140 | 80 | 7 | M27550 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 1.45e-05 | 257 | 80 | 9 | MM14755 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 1.49e-05 | 141 | 80 | 7 | MM15266 | |
| Pathway | WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS | TUBA3D GRIN1 GRIN2C TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A PIK3CB LRP5 | 1.49e-05 | 326 | 80 | 10 | M39379 |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 1.61e-05 | 95 | 80 | 6 | M6729 | |
| Pathway | REACTOME_KINESINS | 1.72e-05 | 57 | 80 | 5 | MM15714 | |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | 1.73e-05 | 200 | 80 | 8 | M864 | |
| Pathway | REACTOME_PROTEIN_FOLDING | 1.92e-05 | 98 | 80 | 6 | M776 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 2.06e-05 | 205 | 80 | 8 | M752 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | CACNA2D2 TUBA3D GRIN1 GRIN2C TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A | 2.15e-05 | 270 | 80 | 9 | M15514 |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 2.15e-05 | 100 | 80 | 6 | M27650 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 2.34e-05 | 273 | 80 | 9 | M983 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | TUBA3D SPTB SPTBN2 COL6A5 GRIN1 TUBA8 ITGB3 TUBA4A TUBA1B TUBA1A PIK3CB SEMA4A | 2.42e-05 | 502 | 80 | 12 | MM14537 |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | MYH10 ANK2 RBBP4 TUBA3D SPTB SPTBN2 DPPA2 SREBF2 COL6A5 GRIN1 TUBA8 ITGB3 CREBBP TUBA4A TUBA3C TUBA1B TUBA1A PIK3CB SEMA4A UTRN EP300 | 3.37e-05 | 1432 | 80 | 21 | M509 |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 4.09e-05 | 68 | 80 | 5 | MM14921 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 4.61e-05 | 168 | 80 | 7 | MM14785 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 4.99e-05 | 116 | 80 | 6 | MM14855 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 5.76e-05 | 73 | 80 | 5 | MM15491 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 5.76e-05 | 73 | 80 | 5 | MM15672 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 8.65e-05 | 323 | 80 | 9 | M27080 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 1.04e-04 | 191 | 80 | 7 | M29614 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 1.10e-04 | 193 | 80 | 7 | MM14890 | |
| Pubmed | 6.49e-14 | 9 | 108 | 6 | 21167302 | ||
| Pubmed | The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro. | 1.57e-12 | 6 | 108 | 5 | 7651436 | |
| Pubmed | 5.49e-12 | 7 | 108 | 5 | 11146551 | ||
| Pubmed | Histone deacetylase 6 regulates human immunodeficiency virus type 1 infection. | 1.46e-11 | 8 | 108 | 5 | 16148047 | |
| Pubmed | 2.05e-11 | 19 | 108 | 6 | 15698476 | ||
| Pubmed | 2.05e-11 | 19 | 108 | 6 | 15691386 | ||
| Pubmed | NES RANBP2 MYH10 ILF2 POLR1A RBBP4 STRBP SPTBN2 YTHDC2 CHD2 YLPM1 UTP20 ZFR HECTD1 UTRN VCL USP47 | 2.06e-11 | 653 | 108 | 17 | 22586326 | |
| Pubmed | Interaction between metabotropic glutamate receptor 7 and alpha tubulin. | 3.28e-11 | 9 | 108 | 5 | 11953448 | |
| Pubmed | 5.58e-11 | 22 | 108 | 6 | 28117675 | ||
| Pubmed | Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity. | 5.58e-11 | 22 | 108 | 6 | 23826228 | |
| Pubmed | ABCB7 ANKFY1 ILF2 ILF3 RGPD8 RBBP4 TUBA8 TUBA4A TUBA3C TUBA1B QSOX1 TUBA1A UGT2A3 HECTD1 CAPN15 | 6.93e-11 | 513 | 108 | 15 | 25798074 | |
| Pubmed | The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis. | 2.05e-10 | 12 | 108 | 5 | 15331610 | |
| Pubmed | HIV-1 rev depolymerizes microtubules to form stable bilayered rings. | 3.32e-10 | 13 | 108 | 5 | 10908577 | |
| Pubmed | 5.15e-10 | 14 | 108 | 5 | 12486001 | ||
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | RANBP2 ILF2 ILF3 ANK2 STRBP TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A ZFR | 9.29e-10 | 271 | 108 | 11 | 32433965 |
| Pubmed | 1.31e-09 | 6 | 108 | 4 | 3785200 | ||
| Pubmed | 1.31e-09 | 6 | 108 | 4 | 16327313 | ||
| Pubmed | 6.64e-09 | 22 | 108 | 5 | 15103018 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MYH10 ANKFY1 POLR1A USP28 YTHDC2 TUBA1A ABRAXAS1 YLPM1 MIOS SASS6 ZFR KLHL8 KDM1B HECTD1 UTRN USP47 RGPD5 | 1.40e-08 | 1005 | 108 | 17 | 19615732 |
| Pubmed | ANK2 USP28 SYNE1 SPTB SPTBN2 CREBBP DMAP1 TUBA1B DIP2A MAP1S OTOF YLPM1 PKD1 CADPS2 CARS2 HECTD1 UTRN EP300 USP47 | 1.55e-08 | 1285 | 108 | 19 | 35914814 | |
| Pubmed | HEY1 functions are regulated by its phosphorylation at Ser-68. | 2.02e-08 | 95 | 108 | 7 | 27129302 | |
| Pubmed | 2.28e-08 | 212 | 108 | 9 | 23463506 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 11163133 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 7519613 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 11121746 | ||
| Pubmed | Tubulin and FtsZ structures: functional and therapeutic implications. | 2.91e-08 | 3 | 108 | 3 | 9722999 | |
| Pubmed | 3.52e-08 | 30 | 108 | 5 | 18603407 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | NES NSUN4 RANBP2 MYH10 ILF2 ILF3 SPOCK1 RBBP4 SYNE1 SPTBN2 CHD2 DMAP1 NWD2 TUBA1A YLPM1 MIOS KDM1B | 4.07e-08 | 1082 | 108 | 17 | 38697112 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | NSUN4 RANBP2 MYH10 ABCB7 STRBP USP28 RFX1 CREBBP DMAP1 TUBA1A UTP20 ZFR KDM1B EP300 USP47 | 6.93e-08 | 857 | 108 | 15 | 25609649 |
| Pubmed | NES MYH10 ILF2 ILF3 ANK2 MYO9A SYNE1 SPTB SPTBN2 YTHDC2 GRIN1 TUBA4A DIP2A NWD2 MAP1S TUBA1A MIOS UTRN VCL | 8.44e-08 | 1431 | 108 | 19 | 37142655 | |
| Pubmed | 9.35e-08 | 250 | 108 | 9 | 33536335 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NES RANBP2 ILF2 ILF3 POLR1A RBBP4 STRBP SYNE1 SPTBN2 YTHDC2 TUBA4A TUBA1B YLPM1 UTP20 ZFR UTRN | 1.15e-07 | 1024 | 108 | 16 | 24711643 |
| Pubmed | SREBP transcriptional activity is mediated through an interaction with the CREB-binding protein. | 1.16e-07 | 4 | 108 | 3 | 8918891 | |
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 18400243 | ||
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 9480752 | ||
| Pubmed | 2.03e-07 | 17 | 108 | 4 | 17360745 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | RANBP2 ILF2 ILF3 POLR1A STRBP YTHDC2 TUBA4A TUBA1B MAP1S TUBA1A LTN1 UTP20 ZFR | 3.03e-07 | 704 | 108 | 13 | 29955894 |
| Pubmed | NES RANBP2 MYH10 ANKFY1 ILF2 ILF3 ANK2 RGPD8 USP28 SYNE1 SPTBN2 GRIN1 YLPM1 MIOS ZFR | 3.08e-07 | 963 | 108 | 15 | 28671696 | |
| Pubmed | NES RANBP2 ILF2 ILF3 RGPD8 MYO9A SYNE1 RNF213 TUBA4A TUBA3C QSOX1 TUBA1A UTRN RGPD5 | 3.74e-07 | 844 | 108 | 14 | 25963833 | |
| Pubmed | RANBP2 UBTD2 MYH10 ILF3 ANK2 RGPD8 SPOCK1 STRBP SYNE1 SPTBN2 DPPA2 CHD2 SNX25 YLPM1 ZFR CADPS2 TASOR RGPD5 | 4.75e-07 | 1442 | 108 | 18 | 35575683 | |
| Pubmed | 5.78e-07 | 6 | 108 | 3 | 20152182 | ||
| Pubmed | 5.78e-07 | 6 | 108 | 3 | 10840040 | ||
| Pubmed | TUBB1 mutations cause thyroid dysgenesis associated with abnormal platelet physiology. | 6.16e-07 | 22 | 108 | 4 | 30446499 | |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 6.89e-07 | 232 | 108 | 8 | 25515538 | |
| Pubmed | 6.92e-07 | 159 | 108 | 7 | 22751105 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NES RANBP2 MYH10 ANKFY1 ILF2 ILF3 POLR1A RBBP4 MYO9A CHD2 CREBBP TUBA4A LTN1 UTP20 ZFR UTRN VCL | 9.40e-07 | 1353 | 108 | 17 | 29467282 |
| Pubmed | An integrated workflow for charting the human interaction proteome: insights into the PP2A system. | 9.77e-07 | 105 | 108 | 6 | 19156129 | |
| Pubmed | 1.01e-06 | 7 | 108 | 3 | 36681692 | ||
| Pubmed | SWAP70 RBBP4 SPTBN2 RFX1 CREBBP DMAP1 YLPM1 ZFR EP300 VCL RGPD5 | 1.19e-06 | 549 | 108 | 11 | 38280479 | |
| Pubmed | 1.58e-06 | 453 | 108 | 10 | 29656893 | ||
| Pubmed | Autism candidate gene DIP2A regulates spine morphogenesis via acetylation of cortactin. | 1.70e-06 | 28 | 108 | 4 | 31600191 | |
| Pubmed | Viral immune modulators perturb the human molecular network by common and unique strategies. | 1.75e-06 | 116 | 108 | 6 | 22810585 | |
| Pubmed | 1.75e-06 | 116 | 108 | 6 | 21282530 | ||
| Pubmed | 2.05e-06 | 187 | 108 | 7 | 26460568 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 2.41e-06 | 475 | 108 | 10 | 31040226 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | NES RANBP2 MYH10 ILF2 ILF3 STRBP USP28 DMAP1 TUBA1B YLPM1 UTP20 ZFR UTP3 VCL | 2.42e-06 | 989 | 108 | 14 | 36424410 |
| Pubmed | RANBP2 MYH10 MYO9A SYNE1 SPTBN2 SREBF2 CREBBP PRKCZ EP300 PACSIN2 | 2.95e-06 | 486 | 108 | 10 | 20936779 | |
| Pubmed | RANBP2 ILF2 ILF3 POLR1A RBBP4 USP28 RNF213 CHD2 CREBBP DMAP1 YLPM1 ZFR KDM1B EP300 | 3.22e-06 | 1014 | 108 | 14 | 32416067 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | ILF2 SPTBN2 UGT1A9 RNF213 CHD2 GRIN1 DIP2A TUBA1A ZFR2 PKD1 UTP20 UTRN | 3.22e-06 | 736 | 108 | 12 | 29676528 |
| Pubmed | 3.40e-06 | 130 | 108 | 6 | 12421765 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 3.41e-06 | 202 | 108 | 7 | 33005030 | |
| Pubmed | 3.41e-06 | 202 | 108 | 7 | 24639526 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MYH10 POLR1A CACNA2D2 RBBP4 MYO9A SPTB SREBF2 RNF213 CHD2 CREBBP ANKRD44 LRP5 PRKCZ HECTD1 ZDHHC13 UTRN EP300 | 3.42e-06 | 1489 | 108 | 17 | 28611215 |
| Pubmed | Cell organization, growth, and neural and cardiac development require αII-spectrin. | 3.44e-06 | 10 | 108 | 3 | 22159418 | |
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | 3.45e-06 | 288 | 108 | 8 | 31501420 | |
| Pubmed | 4.08e-06 | 76 | 108 | 5 | 27542412 | ||
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | NES RANBP2 MYH10 ILF2 ILF3 RGPD8 RBBP4 SPTB TUBA4A TUBA1A RGPD5 | 4.19e-06 | 626 | 108 | 11 | 33644029 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | NSUN4 ILF2 POLR1A RBBP4 STRBP YTHDC2 MIOS UTP20 ZFR UTP3 HECTD1 TASOR | 4.41e-06 | 759 | 108 | 12 | 35915203 |
| Pubmed | Dysferlin interacts with tubulin and microtubules in mouse skeletal muscle. | 4.72e-06 | 11 | 108 | 3 | 20405035 | |
| Pubmed | Functional specialization of beta-arrestin interactions revealed by proteomic analysis. | 6.97e-06 | 317 | 108 | 8 | 17620599 | |
| Pubmed | 7.81e-06 | 322 | 108 | 8 | 26514267 | ||
| Pubmed | Crybb2 coding for βB2-crystallin affects sensorimotor gating and hippocampal function. | 8.14e-06 | 13 | 108 | 3 | 24096375 | |
| Pubmed | 8.14e-06 | 13 | 108 | 3 | 14697242 | ||
| Pubmed | 8.69e-06 | 233 | 108 | 7 | 29518331 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 27881875 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 24920670 | ||
| Pubmed | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | 9.55e-06 | 2 | 108 | 2 | 34845315 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 16901265 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 19729597 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 26240280 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 39287984 | ||
| Pubmed | The E3 ubiquitin ligase, HECTD1, is involved in ABCA1-mediated cholesterol export from macrophages. | 9.55e-06 | 2 | 108 | 2 | 29306077 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 20717166 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 24075808 | ||
| Pubmed | Acetylated α-tubulin is reduced in individuals with poor sperm motility. | 9.55e-06 | 2 | 108 | 2 | 24268707 | |
| Pubmed | NF45 and NF90 Bind HIV-1 RNA and Modulate HIV Gene Expression. | 9.55e-06 | 2 | 108 | 2 | 26891316 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 25893291 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 11559821 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 32576962 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 19822209 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 10574923 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 24522976 | ||
| Pubmed | CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement. | 9.55e-06 | 2 | 108 | 2 | 21847097 | |
| Pubmed | p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes. | 9.55e-06 | 2 | 108 | 2 | 34813504 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 20301699 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 24639469 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 37816914 | ||
| Pubmed | Binding of p300/CBP co-activators by polyoma large T antigen. | 9.55e-06 | 2 | 108 | 2 | 11438528 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 10918613 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 35502657 | ||
| Interaction | GRM7 interactions | 4.71e-10 | 19 | 106 | 6 | int:GRM7 | |
| Interaction | NEK4 interactions | ABCB7 ANKFY1 ILF2 ILF3 RGPD8 RBBP4 ISLR TUBA8 TUBA4A TUBA3C TUBA1B QSOX1 TUBA1A UGT2A3 HECTD1 CAPN15 | 6.35e-08 | 582 | 106 | 16 | int:NEK4 |
| Interaction | TCP11L2 interactions | 6.97e-08 | 21 | 106 | 5 | int:TCP11L2 | |
| Interaction | SIRT6 interactions | RANBP2 ILF3 POLR1A RGPD8 RBBP4 YTHDC2 CREBBP TUBA4A DMAP1 TUBA1A YLPM1 MIOS UTP3 HECTD1 EP300 RGPD5 | 1.79e-07 | 628 | 106 | 16 | int:SIRT6 |
| Interaction | SIRT7 interactions | NES RANBP2 MYH10 ILF2 POLR1A RBBP4 STRBP SPTBN2 YTHDC2 CHD2 YLPM1 UTP20 ZFR HECTD1 UTRN VCL USP47 | 3.31e-07 | 744 | 106 | 17 | int:SIRT7 |
| Interaction | FAM230I interactions | 3.93e-07 | 29 | 106 | 5 | int:FAM230I | |
| Interaction | HEY1 interactions | 7.54e-07 | 140 | 106 | 8 | int:HEY1 | |
| Interaction | SLC35G1 interactions | 9.02e-07 | 34 | 106 | 5 | int:SLC35G1 | |
| Interaction | OBSL1 interactions | NES RANBP2 ILF2 ILF3 POLR1A RBBP4 STRBP SYNE1 SPTBN2 TUBA4A TUBA1B ADPRH YLPM1 UTP20 ZFR UTP3 HECTD1 UTRN | 1.03e-06 | 902 | 106 | 18 | int:OBSL1 |
| Interaction | CIT interactions | NES RANBP2 MYH10 ILF2 ILF3 POLR1A RBBP4 STRBP USP28 STXBP5 SYNE1 SPTB SPTBN2 RNF213 YTHDC2 CHD2 GRIN1 TUBA1A LRRC31 PIK3CB UTP20 ZFR UTP3 | 1.47e-06 | 1450 | 106 | 23 | int:CIT |
| Interaction | BMI1 interactions | RANBP2 ILF2 ILF3 STRBP SYNE1 CREBBP DMAP1 TUBA1B YLPM1 UTP20 ZFR KLHL8 KDM1B TASOR EP300 | 1.84e-06 | 659 | 106 | 15 | int:BMI1 |
| Interaction | SCARNA22 interactions | 2.98e-06 | 118 | 106 | 7 | int:SCARNA22 | |
| Interaction | SLFN11 interactions | RANBP2 MYH10 POLR1A RBBP4 RNF213 YTHDC2 TUBA8 PARP16 LTN1 PRKCZ VCL | 4.70e-06 | 376 | 106 | 11 | int:SLFN11 |
| Interaction | XRCC6 interactions | MYH10 ILF2 ILF3 SWAP70 RBBP4 STRBP YTHDC2 CREBBP TUBA1B TUBA1A LRRC31 YLPM1 ZFR UTP3 HECTD1 EP300 MAST3 | 6.68e-06 | 928 | 106 | 17 | int:XRCC6 |
| Interaction | IFNE interactions | 1.16e-05 | 27 | 106 | 4 | int:IFNE | |
| Interaction | HCST interactions | 1.29e-05 | 205 | 106 | 8 | int:HCST | |
| Interaction | HECTD1 interactions | NSUN4 MYH10 ILF2 POLR1A RBBP4 STRBP YTHDC2 ITGB3 LRRC31 MIOS UTP20 ZFR UTP3 HECTD1 TASOR UTRN EP300 | 1.43e-05 | 984 | 106 | 17 | int:HECTD1 |
| Interaction | YAP1 interactions | MYH10 ILF2 SWAP70 RBBP4 SPTBN2 TUBA8 RFX1 CREBBP TUBA4A TUBA3C DMAP1 TUBA1B TUBA1A YLPM1 ZFR EP300 VCL USP47 | 1.52e-05 | 1095 | 106 | 18 | int:YAP1 |
| Interaction | MYH10 interactions | 1.99e-05 | 359 | 106 | 10 | int:MYH10 | |
| Interaction | ZC2HC1A interactions | 2.18e-05 | 64 | 106 | 5 | int:ZC2HC1A | |
| Interaction | IFI16 interactions | ANKFY1 ILF2 ILF3 RGPD8 RBBP4 SYNE1 RNF213 YTHDC2 RFX1 TUBA1B UTP20 UTP3 TASOR EP300 | 2.24e-05 | 714 | 106 | 14 | int:IFI16 |
| Interaction | TTC5 interactions | 2.35e-05 | 65 | 106 | 5 | int:TTC5 | |
| Interaction | CDH5 interactions | 2.40e-05 | 109 | 106 | 6 | int:CDH5 | |
| Interaction | UNC45A interactions | 2.76e-05 | 228 | 106 | 8 | int:UNC45A | |
| Interaction | TBCB interactions | 3.09e-05 | 114 | 106 | 6 | int:TBCB | |
| Interaction | BAGE2 interactions | 3.38e-05 | 70 | 106 | 5 | int:BAGE2 | |
| Interaction | MECP2 interactions | NES NSUN4 RANBP2 MYH10 ILF2 ILF3 SPOCK1 RBBP4 SYNE1 SPTBN2 CHD2 RFX1 DMAP1 NWD2 TUBA1A YLPM1 MIOS KDM1B EP300 | 3.80e-05 | 1287 | 106 | 19 | int:MECP2 |
| Interaction | RGS14 interactions | 3.98e-05 | 240 | 106 | 8 | int:RGS14 | |
| Interaction | CD79B interactions | 4.53e-05 | 122 | 106 | 6 | int:CD79B | |
| Interaction | PLA2G2A interactions | 4.65e-05 | 38 | 106 | 4 | int:PLA2G2A | |
| Interaction | ADARB1 interactions | ILF3 ANK2 STRBP YTHDC2 TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A ZFR UTP3 | 5.35e-05 | 489 | 106 | 11 | int:ADARB1 |
| Interaction | ATOH1 interactions | 6.43e-05 | 80 | 106 | 5 | int:ATOH1 | |
| Interaction | IGHM interactions | 6.46e-05 | 130 | 106 | 6 | int:IGHM | |
| Interaction | LGR4 interactions | 7.37e-05 | 262 | 106 | 8 | int:LGR4 | |
| Interaction | PPP4R1L interactions | 9.61e-05 | 87 | 106 | 5 | int:PPP4R1L | |
| Interaction | TFCP2 interactions | MYH10 ILF2 SPTBN2 TUBA8 STK35 TUBA4A TUBA3C TUBA1B ADPRH TUBA1A | 1.01e-04 | 436 | 106 | 10 | int:TFCP2 |
| Interaction | LRRC31 interactions | 1.06e-04 | 205 | 106 | 7 | int:LRRC31 | |
| Interaction | TIAM1 interactions | 1.06e-04 | 205 | 106 | 7 | int:TIAM1 | |
| Interaction | NPIPB6 interactions | 1.09e-04 | 18 | 106 | 3 | int:NPIPB6 | |
| Interaction | TP53BP1 interactions | ILF2 ILF3 USP28 GRIN1 RFX1 ITGB3 CREBBP PIK3CB ABRAXAS1 ZFR EP300 | 1.15e-04 | 533 | 106 | 11 | int:TP53BP1 |
| Interaction | OPALIN interactions | 1.19e-04 | 209 | 106 | 7 | int:OPALIN | |
| Interaction | HNRNPC interactions | RANBP2 MYH10 ILF2 ILF3 RBBP4 STRBP TUBA1B ZFR UTP3 EP300 PACSIN2 USP47 | 1.26e-04 | 634 | 106 | 12 | int:HNRNPC |
| Interaction | RGPD1 interactions | 1.28e-04 | 49 | 106 | 4 | int:RGPD1 | |
| Interaction | NEUROG1 interactions | 1.29e-04 | 19 | 106 | 3 | int:NEUROG1 | |
| Interaction | DNAJA2 interactions | MYH10 RBBP4 TUBA4A TUBA1B QSOX1 DIP2A TUBA1A PRKCZ KLHL8 HECTD1 VCL | 1.33e-04 | 542 | 106 | 11 | int:DNAJA2 |
| Interaction | SOX2 interactions | RANBP2 ILF2 ILF3 RBBP4 MYO9A SPTB SPTBN2 YTHDC2 RFX1 TUBA4A DMAP1 TUBA1B QSOX1 TUBA1A YLPM1 ZFR TREX2 UTP3 EP300 | 1.43e-04 | 1422 | 106 | 19 | int:SOX2 |
| Interaction | HDAC4 interactions | RANBP2 ILF2 ILF3 RBBP4 STRBP GCM1 YTHDC2 TUBA4A NWD2 MAP1S MIOS ZFR MAST3 | 1.44e-04 | 744 | 106 | 13 | int:HDAC4 |
| Interaction | EPHB2 interactions | 1.46e-04 | 216 | 106 | 7 | int:EPHB2 | |
| Interaction | MCM2 interactions | RANBP2 ILF2 ILF3 RGPD8 RBBP4 MYO9A SYNE1 RNF213 ITGB3 TUBA4A TUBA3C QSOX1 TUBA1A UTRN EP300 RGPD5 | 1.63e-04 | 1081 | 106 | 16 | int:MCM2 |
| Interaction | ZFR2 interactions | 1.63e-04 | 4 | 106 | 2 | int:ZFR2 | |
| Interaction | FUS interactions | ABCA1 MYH10 ILF2 ILF3 RBBP4 STRBP GRIN1 CREBBP TUBA1B TUBA1A YLPM1 ZFR EP300 | 1.70e-04 | 757 | 106 | 13 | int:FUS |
| Interaction | PRC1 interactions | NES RANBP2 MYH10 ILF2 ILF3 RBBP4 STRBP SYNE1 SPTB SPTBN2 UTP20 ZFR UTP3 HECTD1 VCL | 1.72e-04 | 973 | 106 | 15 | int:PRC1 |
| Interaction | KLF13 interactions | 1.76e-04 | 21 | 106 | 3 | int:KLF13 | |
| Interaction | GRIN2C interactions | 1.76e-04 | 21 | 106 | 3 | int:GRIN2C | |
| Interaction | SIAH1 interactions | 1.78e-04 | 223 | 106 | 7 | int:SIAH1 | |
| Interaction | FLII interactions | 1.79e-04 | 298 | 106 | 8 | int:FLII | |
| Interaction | RGPD4 interactions | 2.03e-04 | 22 | 106 | 3 | int:RGPD4 | |
| Interaction | ACE2 interactions | NES RANBP2 MYH10 ILF2 ILF3 RBBP4 SPTB PTPRU TUBA8 CREBBP TUBA4A TUBA1B TUBA1A YLPM1 ZFR PACSIN2 | 2.11e-04 | 1106 | 106 | 16 | int:ACE2 |
| Interaction | TNPO1 interactions | 2.14e-04 | 306 | 106 | 8 | int:TNPO1 | |
| Interaction | RUVBL1 interactions | MYH10 POLR1A RBBP4 STXBP5 CREBBP TUBA4A DMAP1 TUBA1B TUBA1A HECTD1 USP47 | 2.23e-04 | 575 | 106 | 11 | int:RUVBL1 |
| Interaction | TRIM28 interactions | RANBP2 ILF2 ILF3 POLR1A RBBP4 STRBP YTHDC2 CREBBP TUBA4A TUBA1B MAP1S TUBA1A LTN1 UTP20 ZFR PRKCZ HECTD1 EP300 MAST3 | 2.27e-04 | 1474 | 106 | 19 | int:TRIM28 |
| Interaction | DCPS interactions | 2.35e-04 | 394 | 106 | 9 | int:DCPS | |
| Interaction | CEP97 interactions | 2.39e-04 | 165 | 106 | 6 | int:CEP97 | |
| Interaction | LIPH interactions | 2.47e-04 | 58 | 106 | 4 | int:LIPH | |
| Interaction | SSRP1 interactions | RANBP2 ANKFY1 ILF2 ILF3 POLR1A RBBP4 CHD2 YLPM1 ZFR HECTD1 TASOR EP300 | 2.57e-04 | 685 | 106 | 12 | int:SSRP1 |
| Interaction | CHMP4C interactions | NES MYH10 ILF2 ILF3 MYO9A STRBP SPTB SPTBN2 RNF213 TUBA4A VCL USP47 | 2.64e-04 | 687 | 106 | 12 | int:CHMP4C |
| Interaction | IGSF8 interactions | 2.72e-04 | 239 | 106 | 7 | int:IGSF8 | |
| Interaction | WRN interactions | 2.89e-04 | 110 | 106 | 5 | int:WRN | |
| Interaction | H2BC3 interactions | 2.94e-04 | 406 | 106 | 9 | int:H2BC3 | |
| Interaction | AURKA interactions | ABCB7 ILF2 ILF3 USP28 SREBF2 MAP1S PIK3CB YLPM1 HECTD1 PACSIN2 VCL USP47 | 2.97e-04 | 696 | 106 | 12 | int:AURKA |
| Interaction | BRINP3 interactions | 2.99e-04 | 25 | 106 | 3 | int:BRINP3 | |
| Interaction | SMC2 interactions | 3.09e-04 | 323 | 106 | 8 | int:SMC2 | |
| Interaction | KCTD13 interactions | NES MYH10 ILF2 ILF3 ANK2 MYO9A SYNE1 SPTB SPTBN2 YTHDC2 GRIN1 DIP2A NWD2 MAP1S TUBA1A MIOS UTRN VCL | 3.33e-04 | 1394 | 106 | 18 | int:KCTD13 |
| Interaction | NPAT interactions | 3.60e-04 | 64 | 106 | 4 | int:NPAT | |
| Interaction | RGPD2 interactions | 3.77e-04 | 27 | 106 | 3 | int:RGPD2 | |
| Interaction | GAN interactions | 3.83e-04 | 253 | 106 | 7 | int:GAN | |
| Interaction | SRPK2 interactions | ANKFY1 ILF3 YTHDC2 CHD2 ISLR TUBA1B ADPRH MAP1S OTOF CADPS2 HECTD1 EP300 | 3.88e-04 | 717 | 106 | 12 | int:SRPK2 |
| Interaction | ABT1 interactions | 3.96e-04 | 423 | 106 | 9 | int:ABT1 | |
| Interaction | NUP35 interactions | 4.03e-04 | 424 | 106 | 9 | int:NUP35 | |
| Interaction | UGT2B15 interactions | 4.05e-04 | 6 | 106 | 2 | int:UGT2B15 | |
| Interaction | LTA interactions | 4.21e-04 | 28 | 106 | 3 | int:LTA | |
| Interaction | COPS2 interactions | 4.31e-04 | 258 | 106 | 7 | int:COPS2 | |
| Interaction | AP2M1 interactions | 4.46e-04 | 430 | 106 | 9 | int:AP2M1 | |
| Interaction | CENPV interactions | 4.49e-04 | 121 | 106 | 5 | int:CENPV | |
| Interaction | STARD13 interactions | 4.55e-04 | 68 | 106 | 4 | int:STARD13 | |
| Interaction | USP7 interactions | ABCA1 MAGEL2 ILF3 RGPD8 RBBP4 USP28 SYNE1 SREBF2 ITGB3 CREBBP OTOF SNX25 YLPM1 ZFR KLHL8 UTRN EP300 | 4.82e-04 | 1313 | 106 | 17 | int:USP7 |
| Interaction | BSG interactions | TUBA3D SPTB RNF213 TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A DSTYK UTP20 PRKCZ | 4.89e-04 | 631 | 106 | 11 | int:BSG |
| Interaction | PARP1 interactions | MYH10 ILF2 ILF3 POLR1A SWAP70 STRBP SREBF2 YTHDC2 ITGB3 CREBBP LRRC31 ABRAXAS1 UTP20 UTP3 HECTD1 EP300 MAST3 | 4.94e-04 | 1316 | 106 | 17 | int:PARP1 |
| Interaction | CTDSPL2 interactions | 5.08e-04 | 70 | 106 | 4 | int:CTDSPL2 | |
| Interaction | RNF145 interactions | 5.18e-04 | 30 | 106 | 3 | int:RNF145 | |
| Interaction | KPNA1 interactions | 5.36e-04 | 351 | 106 | 8 | int:KPNA1 | |
| Interaction | EGR1 interactions | 5.65e-04 | 72 | 106 | 4 | int:EGR1 | |
| Interaction | MSH6 interactions | 5.78e-04 | 271 | 106 | 7 | int:MSH6 | |
| Interaction | MYH9 interactions | MYH10 SPTBN2 GRIN1 ITGB3 CREBBP TUBA4A TUBA1B LRRC31 LTN1 EP300 VCL USP47 | 6.07e-04 | 754 | 106 | 12 | int:MYH9 |
| Interaction | RPLP0P6 interactions | 6.22e-04 | 130 | 106 | 5 | int:RPLP0P6 | |
| Interaction | RGPD8 interactions | 6.27e-04 | 74 | 106 | 4 | int:RGPD8 | |
| Interaction | CHD3 interactions | MYH10 ILF2 ILF3 RBBP4 STRBP CREBBP TUBA1B TUBA1A YLPM1 ZFR HECTD1 EP300 | 6.28e-04 | 757 | 106 | 12 | int:CHD3 |
| Interaction | CYLD interactions | MYH10 ANKFY1 ILF2 ILF3 RBBP4 MRPL58 RNF213 COL6A5 TUBA8 TUBA4A TUBA1A SASS6 KDM1B | 6.30e-04 | 868 | 106 | 13 | int:CYLD |
| Interaction | SNRNP70 interactions | RANBP2 MYH10 ILF2 ILF3 STRBP SPTBN2 YTHDC2 TUBA1B LTN1 ZFR KLHL8 HECTD1 CMTR2 EP300 | 6.41e-04 | 984 | 106 | 14 | int:SNRNP70 |
| Interaction | FKBP3 interactions | 6.45e-04 | 131 | 106 | 5 | int:FKBP3 | |
| GeneFamily | Tubulins | 7.59e-10 | 26 | 73 | 6 | 778 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 4.93e-05 | 18 | 73 | 3 | 91 | |
| GeneFamily | UDP glucuronosyltransferases | 2.88e-04 | 32 | 73 | 3 | 363 | |
| GeneFamily | EF-hand domain containing|Spectrins | 3.33e-04 | 7 | 73 | 2 | 1113 | |
| GeneFamily | Glutamate ionotropic receptor NMDA type subunits | 3.33e-04 | 7 | 73 | 2 | 1201 | |
| GeneFamily | SPARC family | 4.43e-04 | 8 | 73 | 2 | 1278 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.10e-03 | 17 | 73 | 2 | 486 | |
| GeneFamily | Ankyrin repeat domain containing | 2.96e-03 | 242 | 73 | 5 | 403 | |
| GeneFamily | Zinc fingers RANBP2-type |RNA binding motif containing | 3.21e-03 | 21 | 73 | 2 | 89 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.45e-09 | 199 | 108 | 9 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.70e-07 | 199 | 108 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.70e-07 | 199 | 108 | 7 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 3.83e-06 | 171 | 108 | 6 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.21e-06 | 186 | 108 | 6 | a1ab273b01971d6a892912560d387685dd657179 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.40e-06 | 187 | 108 | 6 | ef3c85c01bc3da408ae288b6e3096ad888a12e63 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.81e-06 | 189 | 108 | 6 | 3d838da870623a6a278ddc8e6cedca85d9877e50 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.81e-06 | 189 | 108 | 6 | 0e8d1be3c406d1a393e18faccfe89116a8f82bcf | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.67e-06 | 193 | 108 | 6 | c7e9e6e4bf5e07c9cbdf1aa7c8828f4b2500e3ff | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.90e-06 | 194 | 108 | 6 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.90e-06 | 194 | 108 | 6 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | COVID-19_Severe-CD8+_Tem|COVID-19_Severe / Disease condition and Cell class | 8.14e-06 | 195 | 108 | 6 | ff7ae62393e1c858a10592db8e6d9f36b8bae396 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.14e-06 | 195 | 108 | 6 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.62e-06 | 197 | 108 | 6 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | COVID-19_Severe-PLT_0|COVID-19_Severe / Disease Group and Platelet Clusters | 8.62e-06 | 197 | 108 | 6 | dbdeefa72d10f2c5f75ad5aac6f31a892d4e94a9 | |
| ToppCell | COVID-19_Severe-PLT_0|World / Disease Group and Platelet Clusters | 8.87e-06 | 198 | 108 | 6 | d508d69d8de233573aee14f17dd8ef054654aa54 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.13e-06 | 199 | 108 | 6 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega-Platelets|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.13e-06 | 199 | 108 | 6 | b68648b4559e452656dc9e6a0974233e842f5e0d | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega-Platelets|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.40e-06 | 200 | 108 | 6 | e4be88bcef2738915f711b32c95e9c613e7edf96 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Erythro-Megakary-Erythro-Mega-Platelets|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.40e-06 | 200 | 108 | 6 | 326cae37cacd94b423a6ac8873ea56c5abaf0a0b | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T|COVID-19_Severe / Disease, condition lineage and cell class | 9.40e-06 | 200 | 108 | 6 | f72bc3f6606ae77fe1b0a972e35b3ce0727804d9 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 9.40e-06 | 200 | 108 | 6 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.57e-05 | 161 | 108 | 5 | bfb79277889142133ce86492a808f3083a7547e8 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.57e-05 | 161 | 108 | 5 | d6f4b0e4e3b2a4e6232a6de3d67b210e24f8c89d | |
| ToppCell | PCW_13-14-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte2_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.13e-05 | 165 | 108 | 5 | d2ab667ff53f538b12ee4e07ea4b4d118600a228 | |
| ToppCell | PCW_10-12-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte2_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.91e-05 | 170 | 108 | 5 | 3886a77bc3ddbeb42a8149b759fe578871676d6e | |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Megakaryocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.91e-05 | 170 | 108 | 5 | eace4dd09cdbde0fa40a6aa0f3dba1114d0ce475 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l48|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.91e-05 | 170 | 108 | 5 | 070d8683d1a5cc7d594ff0453c961a9bf982c2d0 | |
| ToppCell | T_cells-GNLY+GZMB+_T_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 6.08e-05 | 171 | 108 | 5 | 04c811817cfec45af5f2891793106cc7ddb0300e | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.78e-05 | 175 | 108 | 5 | 334fad1a147de6c007cec5089c02c35cf3220f1b | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.78e-05 | 175 | 108 | 5 | a1e0a15c69211d6db2edeb101476f0f6e08b90c8 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.78e-05 | 175 | 108 | 5 | da191dfb8a7f976a632a3a0b923942ab54f5c8c1 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.96e-05 | 176 | 108 | 5 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 6.96e-05 | 176 | 108 | 5 | bfa1633e1b7a8a2f04d37fa07284fe9bc0199f46 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_GPR21|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.96e-05 | 176 | 108 | 5 | 03d194c9814e12802cd932afade69e868814cb78 | |
| ToppCell | IIF-Other-Platelet|IIF / Disease, Lineage and Cell Type | 7.35e-05 | 178 | 108 | 5 | 529c0d2159e539546876246122f2e999170a6b20 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-05 | 178 | 108 | 5 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | PND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.35e-05 | 178 | 108 | 5 | 9e1f2596fcea5b79cc50b58d83706bb8605e224f | |
| ToppCell | PND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.35e-05 | 178 | 108 | 5 | aa659bd283c4dfbe292cd8698bbf6b1999ca3314 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.35e-05 | 178 | 108 | 5 | bf1d273802a4f42e52ea1bd2a0cae2039559c093 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Megakaryocyte/Platelet|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.54e-05 | 179 | 108 | 5 | 362c003503190dc272fa89185a83a65e063d7a67 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.54e-05 | 179 | 108 | 5 | 479116ac65488c60104a053530830763ec1f95b2 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.54e-05 | 179 | 108 | 5 | 1dfc0cb8b369aef35c59f3d4c52603dc9f3728c1 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.54e-05 | 179 | 108 | 5 | 065a50952e8703fa07767beb6b73a090bf378ca6 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.54e-05 | 179 | 108 | 5 | e0eec8d48868c76c3e879f219357c62ceff1bc76 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.54e-05 | 179 | 108 | 5 | 69a1b3b05c921de6343ffe6ad998aa2b804312a7 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.54e-05 | 179 | 108 | 5 | 7d2e6bde00a9ab4cb21bd48b140ce205e36f9d77 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.95e-05 | 181 | 108 | 5 | 566249e04dd491e6287ad2101b7b1ab11031ed8b | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.95e-05 | 181 | 108 | 5 | db9528dc7cb0230e4c36cb27da69102c588c7ee9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.16e-05 | 182 | 108 | 5 | cc6f9d606a4f8717dc44928ceec2a257636043fd | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.16e-05 | 182 | 108 | 5 | 31efc06d6b073e8e341648207093e5f33c6f9183 | |
| ToppCell | COVID-19_Mild-gd_T|COVID-19_Mild / Disease condition and Cell class | 8.37e-05 | 183 | 108 | 5 | f593a89b0aa8fffdfa403769916facfd30358521 | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 8.37e-05 | 183 | 108 | 5 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.37e-05 | 183 | 108 | 5 | 7c4b775f351794a3de06bd503eecbc8ae8577c44 | |
| ToppCell | COVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class | 8.59e-05 | 184 | 108 | 5 | 791f1bcb954aadc63d4117c400537d036f68734d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_EGR3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.59e-05 | 184 | 108 | 5 | 219bd3b8daa0a713fb6a8a5e1bb35cdb85bb7727 | |
| ToppCell | PBMC-Mild-cDC_9|Mild / Compartment, Disease Groups and Clusters | 8.59e-05 | 184 | 108 | 5 | 2e0c9a2c40c892a2d435eafb31f1f838de9baf15 | |
| ToppCell | COPD-Lymphoid-B|COPD / Disease state, Lineage and Cell class | 8.81e-05 | 185 | 108 | 5 | 925e79c35c381dd44ec5fb921dca09ce43140135 | |
| ToppCell | COPD-Lymphoid-B|World / Disease state, Lineage and Cell class | 8.81e-05 | 185 | 108 | 5 | 22891ed75e25ef30dfa541cb82d85e08ce07e7d9 | |
| ToppCell | PCW_10-12-Hematologic_ErythroMegGranulo-Hem_ErythroMeg|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.04e-05 | 186 | 108 | 5 | 1c39ced3b32dba2832991284720b6c5f508a2e73 | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_Erythro-Mega|bone_marrow / Manually curated celltypes from each tissue | 9.04e-05 | 186 | 108 | 5 | 9ff3c30b1728707bb8f9422941333fe3b2c430f4 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.27e-05 | 187 | 108 | 5 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 9.50e-05 | 188 | 108 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | facs-Tongue-nan-24m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.50e-05 | 188 | 108 | 5 | ed35e438796cef302b6787c111753425922792dc | |
| ToppCell | severe_influenza-Platelet|World / disease group, cell group and cell class (v2) | 9.50e-05 | 188 | 108 | 5 | b54632baa682aaf51100d44e7f114a54d5edd695 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.74e-05 | 189 | 108 | 5 | f57200c93d39c9bce1adba0a6a1c178c028dd86b | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.99e-05 | 190 | 108 | 5 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 | |
| ToppCell | COVID-19_Moderate-Platelet|World / disease group, cell group and cell class | 9.99e-05 | 190 | 108 | 5 | 6e4f4af5ba185bb022753881a26a269a544bb59b | |
| ToppCell | Control-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.05e-04 | 192 | 108 | 5 | 1bfd022d5b87cf8a5d5069f559339a553a52a0a2 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-04 | 192 | 108 | 5 | c5f8e766453f87847b740d6988c524b3d0ef3765 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-04 | 192 | 108 | 5 | dc40ef2341e5d6a6d479f140e023fe1bf687928d | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.07e-04 | 193 | 108 | 5 | 315840bc48899f3a36d57b19197509de19716e3d | |
| ToppCell | 10x5'-blood|World / Manually curated celltypes from each tissue | 1.07e-04 | 193 | 108 | 5 | 359d4242a7e5e51a3eaf6fe51bc1c653a402b054 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.07e-04 | 193 | 108 | 5 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.07e-04 | 193 | 108 | 5 | 3ed46f5a7419ec4eddbd0df0d9b5f53aa486198b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.07e-04 | 193 | 108 | 5 | 658c2b30a4d806c5ce78ea4392fe8eb86b8d1e99 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 193 | 108 | 5 | 5fb7808dd971c1cc64c2bd4f8f1de646fb2d77f4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.10e-04 | 194 | 108 | 5 | 83863da11dfbe59b2d0a2c08db40b537c150588c | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.10e-04 | 194 | 108 | 5 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | 10x5'-blood-Hematopoietic_Erythro-Mega-Megakaryocyte_early|blood / Manually curated celltypes from each tissue | 1.10e-04 | 194 | 108 | 5 | 63dea7d630962761a70aa88e720ee35c22cbc81a | |
| ToppCell | 10x5'-blood-Hematopoietic_Erythro-Mega|blood / Manually curated celltypes from each tissue | 1.10e-04 | 194 | 108 | 5 | d0e7d35b5086834929c4bd39d4c6719b2d5fc71e | |
| ToppCell | Control-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 1.10e-04 | 194 | 108 | 5 | a01de094f7bfd099bcbb2f94224690a2efb887b4 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.13e-04 | 195 | 108 | 5 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-gd_T|COVID-19_Severe / Disease group, lineage and cell class | 1.13e-04 | 195 | 108 | 5 | 9990440bda7fac5d00ef80444fab07459be625e1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.16e-04 | 196 | 108 | 5 | 418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.16e-04 | 196 | 108 | 5 | 581fc8c8d42005aacd7b401a2c9d1fc331fb4af7 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.16e-04 | 196 | 108 | 5 | 6beaf0c2799424c59819b286fbb5c1a83d85e4d1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.16e-04 | 196 | 108 | 5 | c35f2349dfe35baa845f790b9f31673dceac54c0 | |
| ToppCell | 368C|World / Donor, Lineage, Cell class and subclass (all cells) | 1.18e-04 | 197 | 108 | 5 | f41211923938e5d7bfe6bf24f604ab386f17ef10 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.18e-04 | 197 | 108 | 5 | 2b3a56bb1d40bc1284a5931c4e7b373660de5402 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-CD8+_Tem|COVID-19_Severe / Disease group, lineage and cell class | 1.18e-04 | 197 | 108 | 5 | f0bac4d5c3160933ac3786cec8dadffb35d711ea | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.18e-04 | 197 | 108 | 5 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.18e-04 | 197 | 108 | 5 | f73ece3aca28c0db5db0f12e026d42c6c36b9efb | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.18e-04 | 197 | 108 | 5 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | T_cells-CTLs|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.18e-04 | 197 | 108 | 5 | 28117cf300e169182571fbad0de1681a484a435a | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.18e-04 | 197 | 108 | 5 | e70e7d97823a762def3970d94a0e897981a6c922 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.18e-04 | 197 | 108 | 5 | bce0135a96910d2bace62a3408a1a6fdac0cf0df | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pre_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.18e-04 | 197 | 108 | 5 | 106b0f9a0425facc634feb7498c9ba2c55edfbf8 | |
| ToppCell | T_cells-CTLs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.18e-04 | 197 | 108 | 5 | 2de34e20915a247bee75aa40495e23c20bb23e18 | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.18e-04 | 197 | 108 | 5 | d4dfb3b561d0783cdbee4e8d27009ad81df695cb | |
| Drug | Epothilone D | 1.53e-09 | 12 | 106 | 5 | DB01873 | |
| Drug | Epothilone B | 1.53e-09 | 12 | 106 | 5 | DB03010 | |
| Drug | MAPS | 3.17e-06 | 191 | 106 | 8 | CID000066161 | |
| Drug | Coomassie blue | 3.30e-06 | 135 | 106 | 7 | CID000019731 | |
| Drug | NSC332598 | 1.27e-05 | 31 | 106 | 4 | CID000615942 | |
| Drug | DTAF | 2.60e-05 | 37 | 106 | 4 | CID000123934 | |
| Drug | alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A | 3.86e-05 | 197 | 106 | 7 | 6930_DN | |
| Drug | Stylophorin | 4.76e-05 | 43 | 106 | 4 | CID000010147 | |
| Drug | C1 11-32 | 7.61e-05 | 18 | 106 | 3 | CID000443077 | |
| Drug | C11131 | 7.61e-05 | 18 | 106 | 3 | CID000443076 | |
| Drug | AC1L1KMJ | 7.71e-05 | 476 | 106 | 10 | CID000030956 | |
| Drug | procaine | 8.19e-05 | 153 | 106 | 6 | CID000004914 | |
| Drug | Z)-combretastatin A-4 | 8.67e-05 | 50 | 106 | 4 | CID000072686 | |
| Drug | T4-G | 9.00e-05 | 19 | 106 | 3 | CID000152424 | |
| Drug | NSC107658 | 9.37e-05 | 306 | 106 | 8 | CID000002919 | |
| Drug | magnesium sulfate | 1.01e-04 | 52 | 106 | 4 | CID000024083 | |
| Drug | N-Ac-D-E | 1.09e-04 | 53 | 106 | 4 | CID000005255 | |
| Drug | MDL 28170 | 1.17e-04 | 54 | 106 | 4 | CID000072430 | |
| Drug | estriol-16-glucuronide | 1.23e-04 | 21 | 106 | 3 | CID000122281 | |
| Drug | bromocolchicine | 1.23e-04 | 21 | 106 | 3 | CID000161518 | |
| Drug | colchifoline | 1.23e-04 | 21 | 106 | 3 | CID000100132 | |
| Drug | Ustiloxin A | 1.23e-04 | 21 | 106 | 3 | CID000164454 | |
| Drug | SRI-3072 | 1.23e-04 | 21 | 106 | 3 | CID000493469 | |
| Drug | 2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE | 1.28e-04 | 4 | 106 | 2 | DB07574 | |
| Drug | 3,4,5-trimethoxyacetophenone | 1.42e-04 | 22 | 106 | 3 | CID000014345 | |
| Drug | AC1L1GIQ | 1.42e-04 | 22 | 106 | 3 | CID000003700 | |
| Drug | 2,4-dichlorobenzyl thiocyanate | 1.42e-04 | 22 | 106 | 3 | CID000098538 | |
| Drug | SureCN13401588 | 1.42e-04 | 22 | 106 | 3 | CID009897422 | |
| Drug | N-methyldemecolcine | 1.42e-04 | 22 | 106 | 3 | CID000023759 | |
| Drug | NSC-339672 | 1.42e-04 | 22 | 106 | 3 | CID000433930 | |
| Drug | Trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A | 1.61e-04 | 173 | 106 | 6 | 1659_UP | |
| Drug | 3,4,5-trimethoxybenzaldehyde | 1.62e-04 | 23 | 106 | 3 | CID000006858 | |
| Drug | AC1L2P05 | 1.62e-04 | 23 | 106 | 3 | CID000125688 | |
| Drug | estradiol-3-glucuronide | 1.62e-04 | 23 | 106 | 3 | CID000066651 | |
| Drug | 2,3,4-tabp | 1.62e-04 | 23 | 106 | 3 | CID000125548 | |
| Drug | NSC-373301 | 1.62e-04 | 23 | 106 | 3 | CID000341375 | |
| Drug | NSC355636 | 1.62e-04 | 23 | 106 | 3 | CID000100176 | |
| Drug | IKP104 | 1.62e-04 | 23 | 106 | 3 | CID000130739 | |
| Drug | fluorescein-colchicine | 1.62e-04 | 23 | 106 | 3 | CID003035871 | |
| Drug | 3-demethylthiocolchicine | 1.62e-04 | 23 | 106 | 3 | CID000084076 | |
| Drug | 2,3,4-TCB | 1.62e-04 | 23 | 106 | 3 | CID000129239 | |
| Drug | N-acetylcolchinol | 1.62e-04 | 23 | 106 | 3 | CID000097865 | |
| Drug | NSC339663 | 1.71e-04 | 250 | 106 | 7 | CID000003892 | |
| Drug | UDP-alpha-d-xylopyranose | 1.77e-04 | 60 | 106 | 4 | CID000001165 | |
| Drug | Trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 1.82e-04 | 177 | 106 | 6 | 1072_UP | |
| Drug | parbendazole | 1.85e-04 | 24 | 106 | 3 | CID000026596 | |
| Drug | tropolone methyl ether | 1.85e-04 | 24 | 106 | 3 | CID000016546 | |
| Drug | 7-epi-cephalomannine | 1.85e-04 | 24 | 106 | 3 | CID000330401 | |
| Drug | NABV | 1.85e-04 | 24 | 106 | 3 | CID000175959 | |
| Drug | AC1L4TG7 | 1.85e-04 | 24 | 106 | 3 | CID000163705 | |
| Drug | moscatilin | 1.85e-04 | 24 | 106 | 3 | CID000176096 | |
| Drug | NSC-36768 | 1.85e-04 | 24 | 106 | 3 | CID000165441 | |
| Drug | deacetamidocolchicine | 1.85e-04 | 24 | 106 | 3 | CID000014995 | |
| Drug | colchicide | 1.85e-04 | 24 | 106 | 3 | CID000120712 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.93e-04 | 179 | 106 | 6 | 7005_UP | |
| Drug | HU-211 | 1.95e-04 | 114 | 106 | 5 | CID000107778 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 2.05e-04 | 181 | 106 | 6 | 6276_UP | |
| Drug | mpMap | 2.09e-04 | 25 | 106 | 3 | CID000100806 | |
| Drug | AC1Q6P06 | 2.09e-04 | 25 | 106 | 3 | CID000160263 | |
| Drug | allocolchicine | 2.09e-04 | 25 | 106 | 3 | CID000196989 | |
| Drug | 1069C85 | 2.09e-04 | 25 | 106 | 3 | CID006918099 | |
| Drug | 55623-37-5 | 2.09e-04 | 25 | 106 | 3 | CID006438440 | |
| Drug | MDL 27048 | 2.09e-04 | 25 | 106 | 3 | CID006439188 | |
| Drug | NBD-colcemid | 2.09e-04 | 25 | 106 | 3 | CID000130594 | |
| Drug | 2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone | 2.09e-04 | 25 | 106 | 3 | CID000043264 | |
| Drug | CA1P | 2.09e-04 | 25 | 106 | 3 | CID006918545 | |
| Drug | peloruside A | 2.09e-04 | 25 | 106 | 3 | CID006918506 | |
| Drug | NSC142227 | 2.09e-04 | 25 | 106 | 3 | CID000073427 | |
| Drug | 5-(alpha-methyl-4-bromobenzylamino)phosphonomethyl-1,4-dihydroquinoxaline-2,3-dione | 2.13e-04 | 5 | 106 | 2 | ctd:C498554 | |
| Drug | 2-Aminoadipic Acid | 2.13e-04 | 5 | 106 | 2 | ctd:D015074 | |
| Drug | (2S*,3R*)-1-(biphenyl-4-carbonyl)piperazine-2,3-dicarboxylic acid | 2.13e-04 | 5 | 106 | 2 | ctd:C491996 | |
| Drug | 3,4-dimethoxy-N-((2,2-dimethyl-2H-chromen-6-yl)methyl)-N-phenylbenzenesulfonamide | 2.13e-04 | 5 | 106 | 2 | ctd:C575894 | |
| Drug | SDZ EAA 494 | 2.13e-04 | 5 | 106 | 2 | ctd:C065286 | |
| Drug | NSC527981 | 2.36e-04 | 26 | 106 | 3 | CID000352796 | |
| Drug | NSC332029 | 2.36e-04 | 26 | 106 | 3 | CID000100073 | |
| Drug | indibulin | 2.36e-04 | 26 | 106 | 3 | CID000002929 | |
| Drug | pironetin | 2.36e-04 | 26 | 106 | 3 | CID006438891 | |
| Drug | isaxonine | 2.36e-04 | 26 | 106 | 3 | CID000071169 | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 2.45e-04 | 187 | 106 | 6 | 6978_UP | |
| Drug | MgCl2 | 2.53e-04 | 354 | 106 | 8 | CID000024584 | |
| Drug | AC1L1J4H | 2.64e-04 | 27 | 106 | 3 | CID000004862 | |
| Drug | dinitroanilines | 2.64e-04 | 27 | 106 | 3 | CID000136400 | |
| Drug | NSC292222 | 2.64e-04 | 27 | 106 | 3 | CID000099957 | |
| Drug | NSC D-669356 | 2.64e-04 | 27 | 106 | 3 | CID000178028 | |
| Drug | LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 2.67e-04 | 190 | 106 | 6 | 1074_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.90e-04 | 193 | 106 | 6 | 6967_DN | |
| Drug | NSC 370147 | 2.95e-04 | 28 | 106 | 3 | CID000182762 | |
| Drug | NSC72302 | 2.95e-04 | 28 | 106 | 3 | CID000118078 | |
| Drug | Methoxy-6-harmalan [3589-73-9]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 2.98e-04 | 194 | 106 | 6 | 2893_UP | |
| Drug | Felodipine [72509-76-3]; Down 200; 10.4uM; HL60; HT_HG-U133A | 2.98e-04 | 194 | 106 | 6 | 2433_DN | |
| Drug | Galanthamine hydrobromide [1953-04-4]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 2.98e-04 | 194 | 106 | 6 | 4772_DN | |
| Drug | aspirin, USP; Down 200; 100uM; PC3; HT_HG-U133A | 3.06e-04 | 195 | 106 | 6 | 4428_DN | |
| Drug | Meperidine | 3.18e-04 | 6 | 106 | 2 | DB00454 | |
| Drug | Naphthols | 3.18e-04 | 6 | 106 | 2 | ctd:D009284 | |
| Drug | Ajmaline [4360-12-7]; Up 200; 12.2uM; HL60; HG-U133A | 3.24e-04 | 197 | 106 | 6 | 1749_UP | |
| Drug | bp U | 3.28e-04 | 29 | 106 | 3 | CID000368697 | |
| Drug | 7-hydroxycoumarin glucuronide | 3.28e-04 | 29 | 106 | 3 | CID000125641 | |
| Drug | oxibendazole | 3.28e-04 | 29 | 106 | 3 | CID000004622 | |
| Drug | Aids106696 | 3.28e-04 | 29 | 106 | 3 | CID006475933 | |
| Drug | ddGDP | 3.28e-04 | 29 | 106 | 3 | CID000134739 | |
| Disease | microlissencephaly (implicated_via_orthology) | 4.61e-14 | 8 | 104 | 6 | DOID:0112234 (implicated_via_orthology) | |
| Disease | lissencephaly 3 (implicated_via_orthology) | 4.61e-14 | 8 | 104 | 6 | DOID:0112232 (implicated_via_orthology) | |
| Disease | polymicrogyria (implicated_via_orthology) | 4.61e-14 | 8 | 104 | 6 | DOID:0080918 (implicated_via_orthology) | |
| Disease | lissencephaly (implicated_via_orthology) | 4.62e-10 | 27 | 104 | 6 | DOID:0050453 (implicated_via_orthology) | |
| Disease | Menke-Hennekam syndrome | 1.23e-05 | 2 | 104 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 1.23e-05 | 2 | 104 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 1.23e-05 | 2 | 104 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 1.23e-05 | 2 | 104 | 2 | C4551859 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 1.23e-05 | 2 | 104 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 1.23e-05 | 2 | 104 | 2 | cv:C4551859 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 1.23e-05 | 2 | 104 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | Rubinstein-Taybi Syndrome | 1.23e-05 | 2 | 104 | 2 | C0035934 | |
| Disease | nephrosis (biomarker_via_orthology) | 6.24e-05 | 22 | 104 | 3 | DOID:2527 (biomarker_via_orthology) | |
| Disease | Osteoporosis, Age-Related | 6.51e-05 | 61 | 104 | 4 | C0001787 | |
| Disease | Post-Traumatic Osteoporosis | 6.51e-05 | 61 | 104 | 4 | C0751406 | |
| Disease | Osteoporosis, Senile | 6.51e-05 | 61 | 104 | 4 | C0029459 | |
| Disease | autosomal dominant polycystic kidney disease (is_implicated_in) | 7.35e-05 | 4 | 104 | 2 | DOID:898 (is_implicated_in) | |
| Disease | spinocerebellar ataxia type 5 (implicated_via_orthology) | 7.35e-05 | 4 | 104 | 2 | DOID:0050882 (implicated_via_orthology) | |
| Disease | Osteoporosis | 7.39e-05 | 63 | 104 | 4 | C0029456 | |
| Disease | Ischemic stroke | 1.54e-04 | 324 | 104 | 7 | HP_0002140 | |
| Disease | polycystic liver disease (implicated_via_orthology) | 2.55e-04 | 7 | 104 | 2 | DOID:0050770 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 2.86e-04 | 163 | 104 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | DPAGT1 ANK2 STRBP SYNE1 SREBF2 UGT1A9 KCNT2 OTOF PIK3CB ABRAXAS1 UTP20 EP300 | 4.05e-04 | 1074 | 104 | 12 | C0006142 |
| Disease | Drug habituation | 7.46e-04 | 115 | 104 | 4 | C0013170 | |
| Disease | Substance-Related Disorders | 7.46e-04 | 115 | 104 | 4 | C0236969 | |
| Disease | Drug abuse | 7.46e-04 | 115 | 104 | 4 | C0013146 | |
| Disease | Drug Use Disorders | 7.46e-04 | 115 | 104 | 4 | C0013222 | |
| Disease | Drug Dependence | 7.46e-04 | 115 | 104 | 4 | C1510472 | |
| Disease | Substance Dependence | 7.46e-04 | 115 | 104 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 7.46e-04 | 115 | 104 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 7.46e-04 | 115 | 104 | 4 | C0029231 | |
| Disease | Prescription Drug Abuse | 7.46e-04 | 115 | 104 | 4 | C4316881 | |
| Disease | Substance abuse problem | 7.70e-04 | 116 | 104 | 4 | C0740858 | |
| Disease | Colorectal Carcinoma | 8.55e-04 | 702 | 104 | 9 | C0009402 | |
| Disease | Diffuse Large B-Cell Lymphoma | 9.77e-04 | 55 | 104 | 3 | C0079744 | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 1.09e-03 | 14 | 104 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 1.09e-03 | 14 | 104 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | mood instability measurement | 1.11e-03 | 128 | 104 | 4 | EFO_0008475 | |
| Disease | Tremor, Rubral | 1.43e-03 | 16 | 104 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 1.43e-03 | 16 | 104 | 2 | C0750937 | |
| Disease | Ataxia, Motor | 1.43e-03 | 16 | 104 | 2 | C0278161 | |
| Disease | Abnormal coordination | 1.43e-03 | 16 | 104 | 2 | C0520966 | |
| Disease | vision disorder | 1.43e-03 | 16 | 104 | 2 | MONDO_0021084 | |
| Disease | Ataxia, Truncal | 1.43e-03 | 16 | 104 | 2 | C0427190 | |
| Disease | Ataxia, Sensory | 1.43e-03 | 16 | 104 | 2 | C0240991 | |
| Disease | gestational age | 1.47e-03 | 138 | 104 | 4 | EFO_0005112 | |
| Disease | Bipolar Disorder | 1.52e-03 | 477 | 104 | 7 | C0005586 | |
| Disease | Hypercholesterolemia, Familial | 1.81e-03 | 18 | 104 | 2 | C0020445 | |
| Disease | Congenital Myasthenic Syndromes, Presynaptic | 2.02e-03 | 19 | 104 | 2 | C0751884 | |
| Disease | glomerulonephritis (is_marker_for) | 2.02e-03 | 19 | 104 | 2 | DOID:2921 (is_marker_for) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.09e-03 | 152 | 104 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | prostate cancer (is_marker_for) | 2.29e-03 | 156 | 104 | 4 | DOID:10283 (is_marker_for) | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 2.35e-03 | 157 | 104 | 4 | DOID:224 (biomarker_via_orthology) | |
| Disease | Arthrogryposis | 2.47e-03 | 21 | 104 | 2 | C0003886 | |
| Disease | haptoglobin measurement | 2.47e-03 | 21 | 104 | 2 | EFO_0004640 | |
| Disease | mean platelet volume | STXBP5 TUBA8 ITGB3 PIK3CB DSTYK ITPRIP KLHL8 TASOR ALOX12 PACSIN2 | 3.24e-03 | 1020 | 104 | 10 | EFO_0004584 |
| Disease | Mechanical Allodynia | 3.30e-03 | 84 | 104 | 3 | C2936719 | |
| Disease | Allodynia | 3.30e-03 | 84 | 104 | 3 | C0458247 | |
| Disease | Hyperalgesia, Secondary | 3.30e-03 | 84 | 104 | 3 | C0751212 | |
| Disease | Hyperalgesia, Primary | 3.30e-03 | 84 | 104 | 3 | C0751211 | |
| Disease | Hyperalgesia, Thermal | 3.30e-03 | 84 | 104 | 3 | C0751214 | |
| Disease | Tactile Allodynia | 3.30e-03 | 84 | 104 | 3 | C0751213 | |
| Disease | Hyperalgesia | 3.30e-03 | 84 | 104 | 3 | C0020429 | |
| Disease | Autism Spectrum Disorders | 3.41e-03 | 85 | 104 | 3 | C1510586 | |
| Disease | Ataxia | 3.50e-03 | 25 | 104 | 2 | C0004134 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HKALDLDDRWQFKRS | 346 | Q6UWZ7 | |
| DKHLEFSSLRRAQWS | 1636 | Q09472 | |
| RLADAAENFQKAHRW | 136 | Q9NY47 | |
| LDWTAQDIVAFLAKH | 456 | O95477 | |
| AFLTLARDKHWEFSS | 1666 | Q92793 | |
| LDFLWDLNAAIAKRH | 736 | Q8IYT2 | |
| ANHTLIFFDLWRLSK | 556 | A7MBM2 | |
| LSANHALAWLEASKD | 1066 | Q9ULI1 | |
| WNLALIFHRKAEDIE | 681 | P49792 | |
| VWDVEATLNFLKAHF | 521 | O00391 | |
| WNLALIFHRKAEDIE | 681 | Q99666 | |
| WNLALIFHRKAEDIE | 681 | O14715 | |
| AADWKAGQLDARLHE | 446 | Q8IWB1 | |
| LFNHLAETLSSWEAK | 456 | O94822 | |
| HRKAAQAFLSDWTAS | 1051 | O75808 | |
| DQSHALLKYWLERDG | 3611 | Q01484 | |
| AHKFVLAARSDSWSL | 81 | Q9P2R3 | |
| AVLDALLASKQHWDR | 991 | Q66K74 | |
| AVSAARAHLPAAWKN | 761 | Q9UJ55 | |
| WADAKLSFIHRANLD | 211 | O75197 | |
| KSLDLSHNLISDFAW | 101 | O14498 | |
| LGFADDVLNLRWRHK | 111 | Q9H3H5 | |
| ANEAWKDFHGSLLRF | 46 | Q9P2G9 | |
| RLAAALKALNAHWSA | 416 | P07202 | |
| VHLSALEVFNLSWNK | 391 | Q6UY01 | |
| SWRAHADDELAALRA | 51 | P48681 | |
| RLHDSWKFAGELEQA | 166 | Q8N7Z2 | |
| ARDLISRLHDSWKFA | 111 | H0YM25 | |
| INAFDKKDRRALHWA | 166 | Q8N8A2 | |
| DHQTILRAWAVKDFA | 396 | Q6UVM3 | |
| LLAKSWVRNSDFQLH | 341 | P18054 | |
| AFERCASKDHLWNNV | 851 | Q6XUX3 | |
| WDLRNLKLKLHSFES | 301 | Q09028 | |
| LVNNFAAWDHVSAKL | 76 | Q96CB9 | |
| AFLHLLAEVDKWQAE | 1356 | Q92729 | |
| LLQSSGDNHKRAWDL | 71 | Q8N5Y8 | |
| AADAVEDLRWFRANH | 276 | Q9UNF0 | |
| HTEWARLALFDFLLQ | 416 | Q9UFP1 | |
| ADAAFLRHWKLTGTN | 1921 | Q9ULT8 | |
| HFNALLDVVSEWRKD | 486 | Q8NB78 | |
| WAFLGVDEAHRLKND | 611 | O14647 | |
| AWTKAETDHLFDLSR | 151 | Q9NPF5 | |
| LLEVNRFALASHFLW | 406 | P35790 | |
| HLNAQFLRSLWDTFK | 1281 | A8TX70 | |
| AWSKNAALGRNHLAD | 296 | Q9NP62 | |
| ALAAIRHARWFEENA | 201 | Q12905 | |
| ALASLRHAKWFQARA | 206 | Q12906 | |
| NSKAEVRFHLATAEW | 96 | Q14197 | |
| LLAEHAEKFWALFTV | 871 | Q86UW7 | |
| DAASWAQIHQKLRDF | 381 | A2IDD5 | |
| LALDWAGLLRHKAEF | 641 | O60307 | |
| KIGWRNDASHLLVFT | 261 | P05106 | |
| LAAAKRADQVGHFLW | 296 | Q14831 | |
| LTASQFLEIWKHFDA | 16 | P22676 | |
| LTNVLDFKRDAGLWH | 551 | Q14689 | |
| SSENLKHGALFWDLA | 81 | A0A1B0GTK4 | |
| FHEARSRAALAKGWN | 51 | Q9NQZ2 | |
| ELDKLRNEWASHTAA | 191 | Q6UVJ0 | |
| LLHQSSDRFVAELWK | 606 | P35580 | |
| LSADTKGWVRLQFHA | 231 | Q7Z7J5 | |
| NFEDWLHTFNLLRGK | 1421 | Q9HC10 | |
| ARLTLQIWDADHFSA | 1826 | Q9HC10 | |
| AELQRGFFDKHIWLS | 3251 | P98161 | |
| DHTNFRFLLWRALTK | 816 | O75691 | |
| RAHLEASAEKWNRLL | 2551 | P46939 | |
| SDKRHASDFALWKAA | 221 | Q9HA77 | |
| AREHLSALWKNEGFF | 261 | O95602 | |
| DLIHWLQSAKDRLEF | 6806 | Q8NF91 | |
| IRNFAKSLESWLTHA | 711 | P22670 | |
| RALISFWESVEHLKN | 311 | Q9H3E2 | |
| DNFLRWLHHDASFVA | 221 | Q9H3S1 | |
| LNALASLRHAKWFQA | 196 | Q96SI9 | |
| AAAAAFNKDALLNWL | 871 | P42338 | |
| ALADDTLHLWNLRQK | 116 | Q5T5C0 | |
| ADIHRLFNWLSETLA | 766 | Q9UK61 | |
| WAAAAAAFEKRRHSA | 11 | O75027 | |
| AVLAAGDSWKELAHR | 281 | P54922 | |
| IALWQFLSAHKSEQL | 5076 | Q63HN8 | |
| TTAIAEAWARLDHKF | 381 | P0DPH8 | |
| AEFWALTSLKRRHQN | 246 | Q8TDR2 | |
| LESLAALRHARWFQA | 766 | Q9UPR6 | |
| LHWAAINNRLDLVKF | 86 | Q8IUH4 | |
| SNWLAAGLDKHRADF | 126 | Q9NXC5 | |
| HAARATVAEWKDSLN | 1766 | O15020 | |
| WDALKAAAHAFESND | 71 | Q8WUN7 | |
| SVTFWRHRKQADLDL | 571 | Q12772 | |
| TTAIAEAWARLDHKF | 381 | P0DPH7 | |
| ILAAAQSLHREATKW | 966 | P18206 | |
| FADSHLWKLLDRHAN | 806 | Q96K76 | |
| LASRLKDWFGALHED | 206 | Q08629 | |
| DADDLKAWLQDAHRL | 751 | P11277 | |
| KAWLQDAHRLLSGED | 756 | P11277 | |
| HKLLDWLEDAFQLAV | 261 | Q96RU2 | |
| LDREFKAFAHAQWKA | 86 | O60656 | |
| NRLRDWFKALHESGS | 211 | Q9BQ16 | |
| EDARLKQLQAAAAHW | 376 | P49750 | |
| NLAALKLDEWLHFTL | 1101 | Q9H6S0 | |
| DALAALRHAKWFQAR | 901 | Q96KR1 | |
| AKHLRSAAHDLTWFQ | 471 | Q6UWM9 | |
| EELLKAIWHAFTALD | 6 | Q9UH65 | |
| TTAIAEAWARLDHKF | 381 | Q71U36 | |
| FLHRAAELLAWADEQ | 201 | Q9BQ50 | |
| TTAIAEAWARLDHKF | 381 | P68363 | |
| AKHLRVAAHDLTWFQ | 471 | P0DTE4 | |
| TTAIAEAWARLDHKF | 381 | Q9NY65 | |
| TTAIAEAWARLDHKF | 381 | P68366 | |
| DIKSHAFFRSIDWDL | 511 | Q05513 | |
| SAAALLQASWRAHLE | 1076 | B2RTY4 | |
| DSHWKRAIDLALLQF | 766 | Q14957 | |
| VRDNKLHAFIWDSAV | 721 | Q05586 |